Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study.

Liangliang Wang, Shuangying Li, Da Zhu, Yu Qin,Xiaoli Wang,Zhenya Hong,Zhiqiang Han

Journal of gynecologic oncology（2023）

引用 0|浏览12

暂无评分

摘要

Nab-paclitaxel plus platinum as first-line treatment in OC was associated with a favorable prognosis and was tolerable in patients with OC.

查看译文

关键词

Chemotherapy,Nab-paclitaxel,Ovarian Cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要